DELCOR ASSET CORP FDA Approval NDA 050619

NDA 050619

DELCOR ASSET CORP

FDA Drug Application

Application #050619

Documents

Letter2003-05-29

Application Sponsors

NDA 050619DELCOR ASSET CORP

Marketing Status

Discontinued001

Application Products

001PASTILLE;ORAL200,000 UNITS0MYCOSTATINNYSTATIN

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1987-04-09STANDARD
LABELING; LabelingSUPPL2AP1998-11-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1999-02-11STANDARD
LABELING; LabelingSUPPL4AP2003-04-30STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0

CDER Filings

DELCOR ASSET CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50619
            [companyName] => DELCOR ASSET CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"MYCOSTATIN","activeIngredients":"NYSTATIN","strength":"200,000 UNITS","dosageForm":"PASTILLE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MYCOSTATIN","submission":"NYSTATIN","actionType":"200,000 UNITS","submissionClassification":"PASTILLE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.